Fluorescent immunolabeling of cancer cells by quantum dots and antibody scFv fragment

Journal of Biomedical Optics

Volumn 14, Issue 2, 2009, Pages

  Zdobnova, Tatiana A ^a,b   Dorofeev, Sergey G ^c   Tananaev, Piter N ^c   Vasiliev, Roman B ^c   Balandin, Taras G ^a   Edelweiss, Eveline F ^a   Stremovskiy, Oleg A ^a   Balalaeva, Irina V ^b   Turchin, Ilya V ^b   Lebedenko, Ekaterina N ^a   Zlomanov, Vladimir P ^c   Deyev, Sergey M ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b INSTITUTE OF APPLIED PHYSICS   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

4D5 scFv antibody; human breast cancer SKBR 3 cells; human epidermal growth factor receptor 2 neu (HER2 neu); immunolabeling; quantum dots (QDs)

Indexed keywords

4D5 SCFV ANTIBODY; HUMAN BREAST CANCER; HUMAN EPIDERMAL GROWTH FACTOR; IMMUNOLABELING; QUANTUM DOTS (QDS);

ANTIBODIES; CELLS; DISEASES; FLUORESCENCE; PEPTIDES; VISUALIZATION;

SEMICONDUCTOR QUANTUM DOTS;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; QUANTUM DOT;

ARTICLE; BREAST TUMOR; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMAGE ENHANCEMENT; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMAGE ENHANCEMENT; IMMUNOGLOBULIN VARIABLE REGION; MICROSCOPY, FLUORESCENCE; QUANTUM DOTS;

EID: 67650337138     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3122775     Document Type: Article

References (28)

1. K. K., Jain, " Applications of nanobiotechnology in clinical diagnostics, ", Clin. Chem., 53 (11), 2002-2009 (2007). clc CLCHAU 0009-9147 10.1373/clinchem.2007.090795
2. M. V., Yezhelyev, X., Gao, Y., Xing, A., Al-Hajj, S., Nie, and R. M., O'Regan, " Emerging use of nanoparticles in diagnosis and treatment of breast cancer, ", Lancet Oncol., 7 (8), 657-667 (2006). d9q LOANBN 1470-2045 10.1016/S1470-2045(06)70793-8
3. M., Bruchez, M., Moronne, P., Gin, S., Weiss, and A. P., Alivisatos, " Semiconductor nanocrystals as fluorescent biological labels, ", Science, 281 (5385), 2013-2016 (1998). sci SCIEAS 0036-8075 10.1126/science.281. 5385.2013
4. W. C. W., Chan and S., Nie, " Quantum dot bioconjugates for ultrasensitive nonisotopic detection, ", Science, 281 (5385), 2016-2018 (1998). sci SCIEAS 0036-8075 10.1126/science.281.5385.2016
5. X., Gao, Y., Cui, R. M., Levenson, L. W. K., Chung, and S., Nie, " In vivo, cancer targeting and imaging with semiconductor quantum dots, ", Nat. Biotechnol., 22 (8), 969-976 (2004). nab NABIF9 1087-0156 10.1038/nbt994
6. J. S., Ross and J. A., Fletcher, " The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy, ", Oncologist, 3 (4), 237-252 (1998). d33 OCOLF6 1083-7159
7. R. A., Nunes and L. N., Harris, " The HER2 extracellular domain as a prognostic and predictive factor in breast cancer, ", Clin. Breast Cancer, 3 (2), 125-135 (2002). 10.3816/CBC.2002.n.017
8. X., Wu, H., Liu, J., Liu, K. N., Haley, J., Treadway, J. P., Larson, N., Ge, F., Peale, and M. P., Bruchez, " Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots, ", Nat. Biotechnol., 21 (1), 41-46 (2003). nab NABIF9 1087-0156 10.1038/nbt764
9. S., Li-Shishido, T. M., Watanabe, H., Tada, H., Higuchi, and N., Ohuchi, " Reduction in nonfluorescence state of quantum dots on an immunofluorescence staining, ", Biochem. Biophys. Res. Commun., 351 (1), 7-13 (2006). bbr BBRCA9 0006-291X 10.1016/j.bbrc.2006.09.159
10. H., Tada, H., Higuchi, T. M., Wanatabe, and N., Ohuchi, " In vivo, real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice, ", Cancer Res., 67 (3), 1138-1144 (2007). cnr CNREA8 0008-5472 10.1158/0008-5472.CAN-06-1185
11. M., Takeda, H., Tada, H., Higuchi, Y., Kobayashi, M., Kobayashi, Y., Sakurai, T., Ishida, and N., Ohuchi, " In vivo, single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine, ", Breast Cancer, 15 (2), 145-152 (2008). 10.1007/s12282-008-0037-0
12. R. E., Bird, K. D., Hardman, J. W., Jacobson, S., Johnson, B. M., Kaufman, S. M., Lee, T., Lee, S. H., Pope, G. S., Riordan, and M., Whitlow. " Single-chain antigen-binding proteins, ", Science, 242 (4877), 423-426 (1988). sci SCIEAS 0036-8075 10.1126/science.3140379
13. P. A., Trail, H. D., King, and G. M., Dubowchik, " Monoclonal antibody drug immunoconjugates for targeted treatment of cancer, ", Cancer Immunol. Immunother., 52 (5), 328-337 (2003). ZZZZZZ 0340-7004
14. A. M., Wu and P. D., Senter, " Arming antibody: prospects and challenges for immunoconjugates, ", Nat. Biotechnol., 23 (9), 1137-1146 (2005). nab NABIF9 1087-0156 10.1038/nbt1141
15. J., Willuda, A., Honegger, R., Waibel, P. A., Schubiger, R., Stahel, U., Zangemeister-Wittke, and A., Plückthun, " High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment, ", Cancer Res., 59 (22), 5758-5767 (1999). cnr CNREA8 0008-5472
16. S. M., Deyev, R., Waibel, E. N., Lebedenko, A. P., Schubiger, and A., Pluckthun, " Design of multivalent complexes using the barnase-barstar module, ", Nat. Biotechnol., 21 (12), 1486-1492 (2003). nab NABIF9 1087-0156 10.1038/nbt916
17. R. B., Vasiliev, S. G., Dorofeev, D. N., Dirin, D. A., Belov, and T. A., Kuznetsova, " Synthesis and optical properties of PbSe and CdSe colloidal quantum dots capped with oleic acid, ", Mendeleev Commun., 14 (4), 169-171 (2004). 964 MENCEX 0959-9436 10.1070/MC2004v014n04ABEH001970
18. X., Peng, J., Wickham, and A. P., Alivisatos, " Kinetics of II-VI and III-V colloidal semiconductor nanocrystal growth: 'focusing' of size distributions, ", J. Am. Chem. Soc., 120 (21), 5343-5344 (1998). acs JACSAT 0002-7863 10.1021/ja9805425
19. I. I., Protasevich, A. A., Schulga, L. I., Vasilieva, K. M., Polyakov, V. M., Lobachov, R. W., Hartley, M. P., Kirpichnikov, and A. A., Makarov, " Key role of barstar Cys-40 residue in the mechanism of heat denaturation of bacterial ribonuclease complexes with barstar, ", FEBS Lett., 445 (2-3), 384-388 (1999). feb FEBLAL 0014-5793 10.1016/S0014-5793(99)00158-1
20. R. W., Hartley, " Barnase and barstar. Expression of its cloned inhibitor permits expression of a cloned ribonucleas, ", J. Mol. Biol., 202 (4), 913-915 (1988). jlb JMOBAK 0022-2836 10.1016/0022-2836(88)90568-2
21. A., Hoshino, K., Fujioka, T., Oku, M., Suga, Y., Sasaki, T. S., Ohta, M., Yasuhara, K., Suzuki, and K., Yamamoto, " Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification, ", Nano Lett., 4 (11), 2163-2169 (2004). a3z NALEFD 1530-6984 10.1021/nl048715d
22. S. M., Deyev and E. N., Lebedenko, " Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design, ", BioEssays, 30 (9), 904-918 (2008). bie BIOEEJ 0265-9247 10.1002/bies.20805
23. C., Bullen and P., Mulvaney, " The effects of chemisorption on the luminescence of CdSe quantum dots, ", Langmuir, 22 (7), 3007-3013 (2006). lan LANGD5 0743-7463 10.1021/la051898e
24. F. L., Xue, J. Y., Chen, J., Guo, C. C., Wang, W. L., Yang, P. N., Wang, and D. R., Lu, " Enhancement of intracellular delivery of CdTe quantum dots (QDs) to living cells by Tat conjugation, ", J. Fluoresc., 17 (2), 149-154 (2007). jff JOFLEN 1053-0509 10.1007/s10895-006-0152-2
25. A., Sukhanova, J., Devy, L., Venteo, H., Kaplan, M., Artemyev, V., Oleinikov, D., Klinov, M., Pluot, J. H., Cohen, and I., Nabiev, " Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells, ", Anal. Biochem., 324 (1), 60-67 (2004). ana ANBCA2 0003-2697 10.1016/j.ab.2003.09.031
26. H., Mattoussi, J. M., Mauro, E. R., Goldman, G. P., Anderson, V. C., Sundar, F. V., Mikulec, and M. G., Bawendi, " Self-assembly of CdSe-ZnS quantum dot bioconjugates using an engineered recombinant protein, ", J. Am. Chem. Soc., 122 (49), 12142-12150 (2000). acs JACSAT 0002-7863 10.1021/ja002535y
27. M. J., Wieduwilt and M. M., Moasser, " The epidermal growth factor receptor family: biology driving targeted therapeutics, ", Cell. Mol. Life Sci., 65, 1566-1584 (2008). 8ba CMLSFI 1420-682X 10.1007/s00018-008-7440-8
28. E. N., Lebedenko, T. G., Balandin, E. F., Edelweiss, O., Georgiev, E. S., Moiseeva, R. V., Petrov, and S. M., Deyev, " Visualization of cancer cells by means of the fluorescent EGFP-barnase protein, ", Dokl. Biochem. Biophys., 414, 120-123 (2007). 10.1134/S1607672907030088